Abstract
Various strains of Clostridium botulinum and C. tetani elaborate a family of eight structurally similar protein neurotoxins. The seven botulinum neurotoxins (types A-G) are distinguished on the basis of their reactions with specific antibodies and are the causative agents of the disease botulism. These toxins act on the peripheral nervous system where they block neuromuscular transmission and induce widespread flaccid paralysis (Shone 1986; Niemann 1991). Tetanus toxin, on the other hand, acts primarily on the central nervous system to disrupt the control mechanisms of polysynapses resulting in the characteristic muscular spasms and convultions of tetanospasm. Although symptomatically very different, the mechanisms of action of botulinum and tetanus toxins are very similar; both are presynaptically acting neurotoxins which inhibit the calcium-mediated secretion of various neurotransmitter substances (Bigalke et al. 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aureli P, Fenicia L, Pasolini B, Gianfranceschi M, McCroskey LM, Hatheway CL (1986) Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 154: 207–211
Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof TC, Niemann H, Jahn R (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160–163
Bigalke H, Heller I, Bizzini B, Habermann E (1981) Tetanus toxin and botulinum toxin inhibit the release and uptake of various transmitter, as studied with particulate fractions from rat brain and spinal chord. Naunyn Schmiedebergs Arch Pharmacol 316: 244–251
Bonventre PF, Kempe LL (1960) Physiology of toxin production by Clostridium botulinum types A and B.I. Growth, autolysis and toxin production. J Bacteriol 79: 18–23
Boroff DA, DasGupta BR (1971) Botulinum toxin. In: microbial toxins. Kadis S, Montie TC, Ajl SJ (eds) vol IIA p1–68 Academic, New York
Cato EP, Hash DE, Holdeman LV, Moore WEC (1982) Electrophoretic study of Clostridium species. J Clin Microbiol 15: 688–702
Cato EP, George WL, Finegold SM (1986) Genus Clostridium. In: Bergey’s manual of systematic bacteriology vol. 2 Sneath PHA, Nair NS, Sharpe ME, Holt JG (eds) Williams and Wilkins, Baltimore, pp 1141–1200
DasGupta BR (1983) Microbial food toxicants: Clostridium botulinum toxins. CRC handbook of foodbome diseases of biological origin. Rechcigl M (ed) CRC Boca Raton, pp 25–56
DasGupta BR, Boroff DA (1967) Chromatographic isolation of haemagglutinin-free neurotoxin from crystalline toxin of Clostridium botulinum type A toxin. Biochem Biophys Acta 147: 603–609
DasGupta BR, Sathyamoorthy V (1984) Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 3: 415–424
Eklund MW, Poysky FT, Meyers JA, Pelroy GA (1974) Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage. Science 186: 456–458
Evans DM, Williams RS, Shone CC, Hambleton P, Melling J, Dolly JO (1986) Botulinum type B neurotoxin. Its purification, iodination and binding to rat brain synaptosomes. Eur J Biochem 154: 409–416
Gerwing J, Dolman CE, Kason DV, Tremaine JH (1966) Purification and characterisation of C. botulinum type B toxin. J Bacteriol 91: 484–487
Gullmar B, Molin N (1967) Effect of nutrients on physiological properties of Clostridium botulinum type E. J Bacteriol 94: 1924–1929
Hall JD, McCroskey LM, Pincomb BJ, Hatheway CL (1985) Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol 21: 654–655
Hambleton P, Griffiths JB, Cameron R, Melling J (1991) A high containment polymodal pilot-plant fermenter- design concepts. J Chem Tech Biotechnol 50: 167–180
Hatheway CL (1976) Toxoid of C. botulinum type F: purification and immunogenicity studies. Appl Environ Microbiol 31: 234–242
Hatheway CL (1988) Botulism. In: Barlows A, Hansler WJ Jr, Ohashi M, Turano A (eds) Laboratory diagnosis of infectious diseases: principles and practice vol 1, bacterial, mycotic and parasitic diseases. Springer, Berlin Heidelberg New York, pp 111–133
Helting TB, Parschat S, Engelhardt H (1979) Structure of tetanus toxin. J Biol Chem 254: 10728–10733
Hepple JR (1965) Large-scale cultivation of Clostridia. J Appl Bacteriol 28: 52–55
Inoue K, Iida H (1970) Conversion to toxigenicity in C. botulinum type C. Jpn J Microbiol 14: 87–89
Iwasaki M, Sakaguchi G (1978) Acid precipitation of C. botulinum type C and D toxins from whole culture by addition of RNA as a precipitation aid. Infect Immun 19: 749–751
Kitamura M, Sakaguchi S, Sakaguchi G (1969) Significance of the 12S toxin of C. botulinum type E. J Bacteriol 98 1173–1178
Kozaki S, Togashi S, Sakaguchi G (1981) Separation of Clostridium botulinum type A derivative toxin into two fragments. Jpn J Med Sci Biol 34: 61–68
Kuarzono H, Shimozowa K, Hosokawa M, Sakaguchi G (1985) Procedure for the large-scale production and purification of C. botulinum C1 toxin for the preparation of toxoid. FEM Microbiol Lett 30: 47–51
Laird WJ, Aaronson W, Silver RP, Habig WH, Hardegree MC (1980) Plasmid-associated toxigenicity in Clostridium tetani. J Infect Dis 142: 623
Lamanna C, Eklund HW, McElroy OE (1946) Botulinum toxin (type A); including a study of shaking with chloroform as a step in the isolation procedure. J Bacteriol 52: 1–13
Latham WC, Bent DF, Levine L (1962) Tetanus toxin production in the absence of protein. Appl Microbiol 10: 146–152
Lynt RK, Solomon HM, Kautter DA (1984) Heat resistance of Clostridium botulinum type G in phosphate buffer. J Food Prot 47: 463–466
McCroskey LM, Hatheway CL, Fenicia L, Pasolini B, Aureli P (1986) Characterisation of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the faeces of an infant with type E botulism. J Clin Microbiol 23: 201–202
Moberg LJ, Sugiyama H (1978) Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex. Appl Environ Microbiol 35: 828–831
Mueller JH, Miller PA (1945) Production of tetanal toxin. J Immunol 50: 377–384
Murayama S, Syuto B, Oguma K, Iida H, Kubo S (1984) Comparison of C. botulinum toxins type D and C1 in molecular property, antigenicity and binding to rat-brain synaptosomes. Eur J Biochem 142: 487–492
Nielsen KE (1966) Growth and toxin production by Clostridium tetani on repeated transfer in culture media. Acta Pathol. Microbiol Scand 77: 542–554
Neimann H (1991) Molecular biology of Clostridial neurotoxins. In: Alouf JE, Freer JH (eds) A sourcebook of bacterial protein Toxins. Academic, New York, pp. 303–348
Notermans S, Hagenaars AM, Kozaki S (1982) The enzyme-linked immunosorbant assay for the detection and determination of C. botulinum toxins A, B and E. Meth Enzymol 84: 223–228
Nukina M, Mochida Y, Sakaguchi S, Sakaguchi G (1988) Purification of botulinum type G progenitor toxin. Zentralbl Bakterial Hyg A 268: 270–272
Prescott LM, Altenbern RA (1967) Detection of bacteriophages from two strains of Clostridium tetani. J Virol 1: 1085–1086
Schiavo G, Montecucco C (1994) Tetanus and botulinum neurotoxins: isolation and assay. Methods Enzymol (in press)
Schiavo G, Benefenati F, Poulani B, Rosetto O, Polverino de Laureto P, DasGupta BR, Montecucco C (1992) Tetanus and botulinum-B neurotoxins block transmitter release by proteolytic clevage of synaptobrevin. Nature 359: 832–835
Schiavo G, Shone CC, Rossetto O, Alexander FCG, Montecucco C (1993a) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem 268: 11516–11519
Schiavo G, Santucci A, DasGupta BR, Mehta PP, Jontes J, Benefeati F, Wilson MC, Montecucco C (1993b) Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335: 99–103
Schmidt JJ, Segal LS (1986) Purification of type E botulinum neurotoxin by high performance ion exchange chromatography. Anal Biochem 156: 213–219
Shone C, Quinn CP, Wait R, Hallis B, Fooks SG, Hambleton P (1993) Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein isoform-2 by botulinum type B neurotoxin. Eur J Biochem 217: 965–971
Shone CC (1986) Clostridium botulinum neurotoxins, their structures and modes of action. In: Watson D (ed) Natural toxicants in foods. Horwood Chichester, pp 11–57
Shone CC, Wilton-Smith P, Appleton N, Hambleton P, Modi N, Gatley S, Melling J (1985) Monoclonal antibody-based immunoassay for C. botulinum type A toxin is comparable to the mouse bioassay. Appl Environ Microbiol 50: 63–67
Shone CC, Tranter HS, Alexander FCG (1992) Purification and radiolabelling of Clostridium botulinum type F neurotoxin. Methods Neurosci 8: 165–179
Siegal LS (1981) Fermentation kinetics of botulinum toxin production (types A, B and E). In: Lewis GE (ed) Biomedical aspects of botulism. Academic, New York, pp 121–128
Söllner T, Whitehead SW, Brunner M, Erdjument-Bromage H, Geromanus S, Tempst P, Rothman JE (1993) SNAP receptors implicated in vesicle fusion and targeting. Nature 362: 318–324
Sugii S, Sakaguchi G (1977) Botulogenic properties of vegetables with special reference to the molecular size of the toxin in them. J Food Safety 1: 53–65
Summanen P (1993) Recent taxonomic changes for anaerobic gram-positive and selected gramnegative organisms. Clin Infect Dis 16 [Suppl 4]: S168–174
Syuto B, Kubo S (1981) Separation and characterisation of heavy and light chains from Clostridium botulinum type C and their reconstitution. J Biol Chem 256: 3712–3717
Takumi K, Kawata T, Hisatsune K (1971) Autolytic enzyme system of C. botulinum, vol II mode of action of autolytic enzymes in C. botulinum type A. Jpn J Microbiol 15: 131–141
Tse T-K, Dolly JO, Hambleton P, Wray D, Melling J (1981) Preparation and characterisation of homogenious preparation of toxin type A from Clostridium botulinum. Eur J Biochem 122: 493–500
Tsunashima I, Sato K, Shoji K, Yoneda M, Amono T (1964) Excess supplementation of certain amino acids to medium and its inhibitory effect on toxin production by Clostridium tetani Biken J 7: 161–163
Wadsworth JDF, Desai M, King HJ, Tranter HS, Hambleton P, Melling J, Dolly JO, Shone CC (1990) Botulinum type F neurotoxin, its purification and binding to rat brain synaptosomes. Biochem J 268: 123–128
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Shone, C.C., Tranter, H.S. (1995). Growth of Clostridia and Preparation of Their Neurotoxins. In: Montecucco, C. (eds) Clostridial Neurotoxins. Current Topics in Microbiology and Immunology, vol 195. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85173-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-85173-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85175-9
Online ISBN: 978-3-642-85173-5
eBook Packages: Springer Book Archive